Drug factory · FDA FEI 3020740318
Amgen Inc.
4150 Ganton Parkway, New Albany, OH, United States
No problems found at FDA's last inspection, Feb 4, 2025.
No Action Indicated: inspectors found no objectionable conditions.
1 drug inspection on record since 2025: 1 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Etelcalcetide | Packages it and labels it | Amgen Inc | 55513-740, 55513-741, 55513-742 |
| Panitumumab | Packages it and labels it | Amgen Inc | 55513-954, 55513-956 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Feb 4, 2025 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; pack.